SLC39A5
Basic information
Region (hg38): 12:56230049-56237846
Links
Phenotypes
GenCC
Source:
- myopia 24, autosomal dominant (Strong), mode of inheritance: AD
- myopia 24, autosomal dominant (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopia 24 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 24891338 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC39A5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 45 | 58 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 1 | 1 | 47 | 13 | 8 |
Highest pathogenic variant AF is 0.00000657
Variants in SLC39A5
This is a list of pathogenic ClinVar variants found in the SLC39A5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-56231261-T-C | Myopia 24, autosomal dominant | Benign (Jul 15, 2021) | ||
12-56231284-T-C | Benign (May 20, 2018) | |||
12-56231287-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
12-56231297-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
12-56231313-C-G | not specified | Likely benign (May 08, 2023) | ||
12-56231330-T-C | Benign (Jun 01, 2022) | |||
12-56231366-C-A | not specified | Uncertain significance (Jan 11, 2023) | ||
12-56231374-C-A | not specified | Uncertain significance (Jan 29, 2024) | ||
12-56231415-C-G | Myopia 24, autosomal dominant | Pathogenic (Aug 01, 2014) | ||
12-56231417-G-A | Uncertain significance (Feb 14, 2023) | |||
12-56231418-C-T | SLC39A5-related disorder | Likely benign (Jul 01, 2022) | ||
12-56231444-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
12-56231451-G-A | Likely benign (Jun 01, 2024) | |||
12-56231453-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
12-56231469-G-A | Likely benign (May 17, 2018) | |||
12-56231498-T-TG | Myopia 24, autosomal dominant | Likely pathogenic (Oct 14, 2020) | ||
12-56231510-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
12-56231565-C-T | SLC39A5-related disorder | Likely benign (May 28, 2019) | ||
12-56232700-C-G | not specified | Uncertain significance (Jul 11, 2023) | ||
12-56232789-C-T | Benign (Dec 13, 2018) | |||
12-56232790-G-A | not specified | Likely benign (Mar 30, 2022) | ||
12-56232792-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
12-56232805-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
12-56232819-C-T | not specified | Likely benign (Sep 17, 2021) | ||
12-56234859-C-G | Likely benign (Sep 10, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC39A5 | protein_coding | protein_coding | ENST00000266980 | 10 | 7798 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.38e-11 | 0.251 | 125440 | 1 | 306 | 125747 | 0.00122 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.238 | 310 | 322 | 0.963 | 0.0000190 | 3342 |
Missense in Polyphen | 136 | 128.92 | 1.0549 | 1428 | ||
Synonymous | 0.403 | 148 | 154 | 0.959 | 0.00000911 | 1315 |
Loss of Function | 0.833 | 18 | 22.2 | 0.809 | 0.00000130 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00195 | 0.00195 |
Ashkenazi Jewish | 0.00124 | 0.00109 |
East Asian | 0.000761 | 0.000761 |
Finnish | 0.000705 | 0.000647 |
European (Non-Finnish) | 0.00155 | 0.00149 |
Middle Eastern | 0.000761 | 0.000761 |
South Asian | 0.00105 | 0.000948 |
Other | 0.00189 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in polarized cells by carrying out serosal-to-mucosal zinc transport. Plays a role in eye development. Could regulate the BMP/TGF-beta (bone morphogenetic protein/transforming growth factor-beta) signaling pathway and modulates extracellular matrix (ECM) proteins of the sclera (PubMed:24891338). Seems to play a central role in controlling organismal zinc status (By similarity). {ECO:0000250|UniProtKB:Q9D856, ECO:0000269|PubMed:24891338}.;
- Disease
- DISEASE: Myopia 24, autosomal dominant (MYP24) [MIM:615946]: A refractive error of the eye, in which parallel rays from a distant object come to focus in front of the retina, vision being better for near objects than for far. {ECO:0000269|PubMed:24891338, ECO:0000269|PubMed:25525168}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Zinc homeostasis;Zinc influx into cells by the SLC39 gene family;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Metal ion SLC transporters;Zinc transporters
(Consensus)
Intolerance Scores
- loftool
- 0.909
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.2
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.416
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.146
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc39a5
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; skeleton phenotype; immune system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- eye development;cellular zinc ion homeostasis;BMP signaling pathway;cellular response to zinc ion starvation;positive regulation of mRNA splicing, via spliceosome;neural precursor cell proliferation;G1 to G0 transition involved in cell differentiation;zinc ion import across plasma membrane
- Cellular component
- integral component of plasma membrane;basolateral plasma membrane;extracellular exosome
- Molecular function
- molecular_function;zinc ion transmembrane transporter activity